57 related articles for article (PubMed ID: 10794815)
41. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory effect of intracerebroventricularly-administered [D-Arg(2), beta-Ala(4)]-dermorphin (1-4) on gastrointestinal transit.
Niijima F; Tan-No K; Esashi A; Nakagawasai O; Tadano T; Takahashi N; Yonezawa A; Sakurada S; Kisara K
Peptides; 2000 Feb; 21(2):295-9. PubMed ID: 10764959
[TBL] [Abstract][Full Text] [Related]
43. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
[TBL] [Abstract][Full Text] [Related]
44. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280
[TBL] [Abstract][Full Text] [Related]
45. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone.
Sakurada S; Hayashi T; Yuhki M; Fujimura T; Murayama K; Yonezawa A; Sakurada C; Takeshita M; Zadina JE; Kastin AJ; Sakurada T
Brain Res; 2000 Oct; 881(1):1-8. PubMed ID: 11033087
[TBL] [Abstract][Full Text] [Related]
46. [Overview in 45 years of studies on peptide chemistry].
Okada Y
Yakugaku Zasshi; 2009 Oct; 129(10):1141-54. PubMed ID: 19797870
[TBL] [Abstract][Full Text] [Related]
47. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
[TBL] [Abstract][Full Text] [Related]
48. The antinociceptive properties of endomorphin-1 and endomorphin-2 in the mouse.
Tseng LF
Jpn J Pharmacol; 2002 Jul; 89(3):216-20. PubMed ID: 12184724
[TBL] [Abstract][Full Text] [Related]
49. Differential antinociceptive effects induced by intrathecally-administered endomorphin-1 and endomorphin-2 in mice.
Sakurada S; Hayashi T; Yuhki M
Jpn J Pharmacol; 2002 Jul; 89(3):221-3. PubMed ID: 12184725
[TBL] [Abstract][Full Text] [Related]
50. The dermorphin peptide family.
Melchiorri P; Negri L
Gen Pharmacol; 1996 Oct; 27(7):1099-107. PubMed ID: 8981054
[TBL] [Abstract][Full Text] [Related]
51. Rational drug design of selective epsilon opioid receptor agonist TAN-821 and antagonist TAN-1014.
Fujii H; Nagase H
Curr Med Chem; 2006; 13(10):1109-18. PubMed ID: 16719773
[TBL] [Abstract][Full Text] [Related]
52. Exploring μ-Opioid Receptor Splice Variants as a Specific Molecular Target for New Analgesics.
Mizoguchi H; Fujii H
Curr Top Med Chem; 2020; 20(31):2866-2877. PubMed ID: 32962616
[TBL] [Abstract][Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
